K71.4
Toxic liver disease with chronic lobular hepatitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Toxic liver disease with chronic lobular hepatitis is a condition characterized by ongoing inflammation of the liver's lobules, often caused by exposure to harmful substances. This condition can impair liver function over time and may lead to more serious liver problems if not properly managed. It is classified under ICD-10 code K71.4, indicating a specific form of toxic liver injury associated with chronic lobular hepatitis.
Causes & Symptoms
Clinical Causes: Prolonged or high-dose exposure to hepatotoxic chemicals and toxins, such as certain medications, industrial chemicals, or environmental pollutants. Chronic alcohol consumption, which can harm liver cells and trigger inflammation. Repetitive use of drugs known to induce liver toxicity. Occupational or environmental exposure to hazardous chemicals. Underlying liver conditions that may predispose to toxic injury.
Key Symptoms: Fatigue and weakness Loss of appetite Nausea and vomiting Right upper abdominal pain or discomfort Jaundice (yellowing of the skin and eyes) Dark urine Pale or clay-colored stool Swelling in the abdomen (ascites) Unintentional weight loss Fever or malaise
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Liver function tests such as ALT, AST, alkaline phosphatase, and bilirubin levels may be elevated, indicating liver damage. A liver biopsy may be performed to analyze tissue samples for signs of lobular inflammation and cellular damage. Imaging studies like ultrasound or MRI can help rule out other liver conditions and assess liver integrity. It is crucial for healthcare providers to consider exposure history to toxins or chemicals that might have contributed to the condition.
Treatment Protocols: Management of toxic liver disease with chronic lobular hepatitis focuses on removing or limiting exposure to harmful substances, supportive care to improve liver health, and monitoring disease progression. Specific treatment strategies include: - Cessation of exposure to hepatotoxic agents. - Discontinuation or adjustment of any medications contributing to liver toxicity. - Supportive treatments such as hydration, nutrition, and medications to manage symptoms. - Use of medications in certain cases to reduce inflammation or support liver regeneration. - Regular monitoring of liver function to assess response to treatment. - In advanced cases, more invasive procedures or liver transplantation may be considered if liver failure develops. Lifestyle modifications, such as avoiding alcohol and maintaining a balanced diet, are also recommended to protect liver health.
Clinical Advice & FAQs
Billing Guidance
Is K71.4 a billable ICD-10 code?
Yes, K71.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K71.4?
Clinical documentation must specify the nature of Toxic liver disease with chronic lobular hepatitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
